
March 4 (Reuters) - SEC Filing:
MAIA BIOTECHNOLOGY INC - ON MARCH 2, CO ENTERS UNDERWRITING AGREEMENT WITH KONIK CAPITAL PARTNERS ON MARCH 2, 2026 - SEC FILING
MAIA BIOTECHNOLOGY INC - TO ISSUE 20,000,000 SHARES OF COMMON STOCK IN PUBLIC OFFERING - SEC FILING
Source text: [ID:n0001493152-26-008897]